Portal de Periódicos da CAPES

Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 system

2019; Informa; Volume: 51; Issue: sup1 Linguagem: Inglês

10.1080/07853890.2018.1561848

1365-2060

Rita Almeida, Susana Bandarra, Ana Clara Ribeiro, Paulo Mascarenhas, Evguenia Bekman, Isabel Barahona,

CRISPR and Genetic Engineering

Introduction: Different cancer cells, including those from breast cancer, show increased APOBEC3 activity [1 Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415–421.[Crossref], [PubMed], [Web of Science ®] , [Google Scholar],2 Roberts SA, Lawrence MS, Klimczak LJ, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nature Genetics. 2013;45:970–976. doi:10.1038/ng.2702[Crossref], [PubMed], [Web of Science ®] , [Google Scholar]], a single strand DNA cytidine deaminase, probably responsible for mutation clusters in tumors. The working hypothesis is that inhibition of APOBEC3 prevents development of mutagenesis-dependent breast cancer cells resistance to chemotherapy. To test this hypothesis, we used breast cancer cell lines that overexpress APOBEC3G and performed a knock-out of APOBEC3G by CRISPR-Cas9 system.Materials and methods: Selected guides against the APOBEC3G gene were cloned into the pX459 plasmid expressing both single guide RNA (sgRNA) and Cas9 protein and verified by Sanger sequencing. The sgRNA constructs were introduced in MCF10A and HCC1806 breast cancer cell lines by lipofection. 24h after transfection puromycin selection was applied for 48h. Genomic DNA was extracted for the detection of the indels caused by double strand break DSB.Results: We have chosen four different pairs of guides to inactivate APOBEC3G gene, using the online tool (http://crispor.tefor.net/). After performing transfection of MCF10A and HCC1806 cells on small scale, the best candidate guides A3Gguide285 and A3Gguide265 (Figure 1) were chosen for further transfection on large scale with the aim of individual clones' isolation. Several clones were obtained and are presently being subjected to genomic DNA analysis for the presence of indels in APOBEC3G gene.Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 systemAll authorsRita Mendes de Almeida, Susana Bandarra, Ana Clara Ribeiro, Paulo Mascarenhas, Evguenia Bekman & Isabel Barahonahttps://doi.org/10.1080/07853890.2018.1561848Published online:28 May 2019Figure 1. Representation of the two selected guides that target the APOBEC3G gene.Display full sizeFigure 1. Representation of the two selected guides that target the APOBEC3G gene.Discussion and conclusions: We have obtained several clones to screen for the successful knock-out of both alleles of the APOBEC3G gene. These cell lines will be used as control, against stably transfected cells expressing both Vif and APOBEC3G proteins to check the effect of Vif/APOBEC3 interaction on chemotherapy resistance.